Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • ID: 3734765
  • Company Profile
  • 49 pages
  • Global Markets Direct
1 of 4
Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

‘Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Anacor Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Anacor Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Anacor Pharmaceuticals, Inc.
- The report provides overview of Anacor Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Anacor Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Anacor Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Anacor Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Anacor Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Anacor Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Anacor Pharmaceuticals, Inc. Snapshot

Anacor Pharmaceuticals, Inc. Overview

Key Information

Key Facts

Anacor Pharmaceuticals, Inc. - Research and Development Overview

Key Therapeutic Areas

Anacor Pharmaceuticals, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Anacor Pharmaceuticals, Inc. - Pipeline Products Glance

Anacor Pharmaceuticals, Inc. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Anacor Pharmaceuticals, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Anacor Pharmaceuticals, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Anacor Pharmaceuticals, Inc. - Drug Profiles

crisaborole

Product Description

Mechanism of Action

R&D Progress

epetraborole

Product Description

Mechanism of Action

R&D Progress

AN-2718

Product Description

Mechanism of Action

R&D Progress

AN-3485

Product Description

Mechanism of Action

R&D Progress

AN-4161

Product Description

Mechanism of Action

R&D Progress

AN-4169

Product Description

Mechanism of Action

R&D Progress

AN-5973

Product Description

Mechanism of Action

R&D Progress

Small Molecule 1 for Tuberculosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule 2 for Tuberculosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Shigellosis

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Chagas Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Leishmaniasis

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Nematodal Diseases

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Skin Inflammation

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit PDE4 for Psoriasis

Product Description

Mechanism of Action

R&D Progress

Anacor Pharmaceuticals, Inc. - Pipeline Analysis

Anacor Pharmaceuticals, Inc. - Pipeline Products by Target

Anacor Pharmaceuticals, Inc. - Pipeline Products by Route of Administration

Anacor Pharmaceuticals, Inc. - Pipeline Products by Molecule Type

Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action

Anacor Pharmaceuticals, Inc. - Recent Pipeline Updates

Anacor Pharmaceuticals, Inc. - Dormant Projects

Anacor Pharmaceuticals, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

epetraborole

Anacor Pharmaceuticals, Inc. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Anacor Pharmaceuticals, Inc., Key Information

Anacor Pharmaceuticals, Inc., Key Facts

Anacor Pharmaceuticals, Inc. - Pipeline by Indication, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Anacor Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Anacor Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016

Anacor Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Anacor Pharmaceuticals, Inc. - Pre-Registration, 2016

Anacor Pharmaceuticals, Inc. - Phase II, 2016

Anacor Pharmaceuticals, Inc. - Phase I, 2016

Anacor Pharmaceuticals, Inc. - Preclinical, 2016

Anacor Pharmaceuticals, Inc. - Discovery, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Target, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Anacor Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016

Anacor Pharmaceuticals, Inc. - Dormant Developmental Projects,2016

Anacor Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016

List of Figures

Anacor Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Anacor Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Anacor Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Target, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Anacor Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll